撒哈拉以南非洲新生儿侵袭性细菌感染病因及抗菌药物耐药性:系统综述与荟萃分析
2008-2018年82项研究中多数STROBE-NI报告条目信息不足。菌血症/脓毒症以金黄色葡萄球菌、克雷伯菌属和大肠埃希菌为主,脑膜炎以B族链球菌、肺炎链球菌和金黄色葡萄球菌为主;对WHO推荐β-内酰胺类耐药达68%,氨基糖苷类耐药27%。
要点
- 医院获得性新生儿感染和抗菌药物耐药是非洲主要负担。
- 菌血症/脓毒症主要病原为金黄色葡萄球菌、克雷伯菌属和大肠埃希菌。
- 脑膜炎主要病原为B族链球菌、肺炎链球菌和金黄色葡萄球菌。
核心结论
- 医院获得性新生儿感染和抗菌药物耐药是非洲的主要负担。
- 需要更多基于人群的新生儿感染研究和改进的常规监测以改善临床护理、规划卫生系统并应对耐药。
- 未来研究应按STROBE-NI等标准化报告指南报告以助比较和减少研究浪费。
研究设计与样本
- 系统综述与荟萃分析,遵循STROBE-NI报告指南。
- 纳入微生物学确诊的侵袭性细菌感染(包括脑膜炎)及耐药数据。
- 按STROBE-NI清单评估科学报告质量。
主要发现
- 2008-2018年82项研究中多数STROBE-NI条目报告细节不足。
- 培养阳性菌血症或脓毒症中金黄色葡萄球菌占25%(95%CI 21-29),克雷伯菌属占21%(16-27),大肠埃希菌占10%(8-10)。
- 脑膜炎主要病原为B族链球菌25%(16-33)、肺炎链球菌17%(9-6)、金黄色葡萄球菌12%(3-25)。
- 对WHO推荐β-内酰胺类耐药为904例中614例(68%),对氨基糖苷类耐药为1176例中317例(27%)。
局限性
- 几乎所有研究为医院基础,数据代表性有限。
- 2008-2018年发表研究多数STROBE-NI条目报告细节不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aetiological data for neonatal infections are essential to inform policies and programme strategies, but such data are scarce from sub-Saharan Africa. We therefore completed a systematic review and meta-analysis of available data from the African continent since 1980, with a focus on regional differences in aetiology and antimicrobial resistance (AMR) in the past decade (2008-18). METHODS: We included data for microbiologically confirmed invasive bacterial infection including meningitis and AMR among neonates in sub-Saharan Africa and assessed the quality of scientific reporting according to Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI) checklist. We calculated pooled proportions for reported bacterial isolates and AMR. FINDINGS: We included 151 studies comprising data from 84 534 neonates from 26 countries, almost all of which were hospital-based. Of the 82 studies published between 2008 and 2018, insufficient details were reported regarding most STROBE-NI items. Regarding culture positive bacteraemia or sepsis, Staphylococcus aureus, Klebsiella spp, and Escherichia coli accounted for 25% (95% CI 21-29), 21% (16-27), and 10% (8-10) respectively. For meningitis, the predominant identified causes were group B streptococcus 25% (16-33), Streptococcus pneumoniae 17% (9-6), and S aureus 12% (3-25). Resistance to WHO recommended β-lactams was reported in 614 (68%) of 904 cases and resistance to aminoglycosides in 317 (27%) of 1176 cases. INTERPRETATION: Hospital-acquired neonatal infections and AMR are a major burden in Africa. More population-based neonatal infection studies and improved routine surveillance are needed to improve clinical care, plan health systems approaches, and address AMR. Future studies should be reported according to standardised reporting guidelines, such as STROBE-NI, to aid comparability and reduce research waste. FUNDING: Uduak Okomo was supported by a Medical Research Council PhD Studentship.
引用
- Okomo U, Akpalu ENK, Le Doare K, et al. Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines. Lancet Infect Dis. 2019. PMID: 31522858. doi:10.1016/S1473-3099(19)30414-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。